WIRE-BLOOMBERG  ·   June 23, 2011

Pfizer, Bristol-Myers Thinner Tops Warfarin for Strokes

- June 23 (Bloomberg) -- Pfizer Inc.'s and Bristol-Myers Squibb Co.'s experimental blood thinner apixaban prevented more strokes with less major bleeding than traditional treatment in patients with irregular heartbeats in a key study. Shannon Pettypiece reports on Bloomberg Television's "In the Loop." (Source: Bloomberg) ()

- June 23 (Bloomberg) -- Pfizer Inc.'s and Bristol-Myers Squibb Co.'s experimental blood thinner apixaban prevented more strokes with less major bleeding than traditional treatment in patients with irregular heartbeats in a key study. Shannon Pettypiece reports on Bloomberg Television's "In the Loop." (Source: Bloomberg) ()

Pfizer, Bristol-Myers Thinner Tops Warfarin for Strokes

buildnumber:0299c0